Stay updated on Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.

Latest updates to the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedExpanded the study's Locations with numerous site regions (Aichi-ken, Chiba, Ehime, Gifu, Gunma, Hiroshima, Hokkaido, Hyōgo, Ishikawa-ken, Iwate, Kanagawa, Miyagi, Nagano, Okayama-ken, Osaka, Saitama, Shizuoka, Tochigi, Tokyo) and added a Revision: v3.3.3.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe Publications section description was updated to indicate that publications are automatically filled from PubMed and may not be about the study, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Tainan, Taiwan as a study location and removed Tainan City, Taiwan from the list of locations.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page content remains unchanged with respect to the study details; any visible differences are likely minor cosmetic or layout adjustments.SummaryDifference0.2%

- Check89 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%

- Check96 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.4%

Stay in the know with updates to Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.